Literature DB >> 4396127

Beta-adrenoceptor antagonist activity of 3-methoxyisoprenaline.

J R Bassett.   

Abstract

1. The beta-adrenoceptor antagonist activity of 3-methoxyisoprenaline, the O-methylated metabolite of isoprenaline, was studied on isolated driven atrial strip and tracheal chain preparations of the guinea-pig and on the hind limb blood flow of the dog.2. On both the atrial strip and tracheal chain preparations the blockade of responses to isoprenaline fulfilled the criteria for simple competitive inhibition.3. 3-Methoxyisoprenaline decreased the vasodilator response to isoprenaline in the dog hind limb, but did not affect the response to noradrenaline.4. 3-Methoxyisoprenaline had about 1/3,700 of the potency of propranolol as a beta-adrenoceptor antagonist on the tracheal chain preparation, 1/1,000 on the atrial strip preparation and less than 1/400 on the hind limb blood flow.5. The antagonist activity of 3-methoxyisoprenaline showed a slight specificity for cardiac beta-adrenoceptors, being 4.3 times more active on guinea-pig atria than on trachea.6. Although 3-methoxyisoprenaline antagonized the actions of isoprenaline in the three preparations, its activity was extremely weak. It is unlikely that the formation of 3-methoxyisoprenaline from isoprenaline, administered therapeutically, could lead to beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4396127      PMCID: PMC1702739          DOI: 10.1111/j.1476-5381.1971.tb09941.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  A COMPARISON OF THE CARDIAC STIMULATING AND BRONCHODILATOR ACTIONS OF SELECTED SYMPATHOMIMETIC AMINES.

Authors:  A M LANDS; T G BROWN
Journal:  Proc Soc Exp Biol Med       Date:  1964-06

2.  Drug antagonism and pAx.

Authors:  H O SCHILD
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

3.  Differentiation of beta-adrenoreceptors by the use of blocking agents.

Authors:  J B Farmer; G P Levy
Journal:  J Pharm Pharmacol       Date:  1970-02       Impact factor: 3.765

4.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  The nature of the adrenergic receptors of the trachea of the guinea-pig.

Authors:  R W Foster
Journal:  J Pharm Pharmacol       Date:  1966-01       Impact factor: 3.765

6.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.

Authors:  W D Conway; H Minatoya; A M Lands; J M Shekosky
Journal:  J Pharm Sci       Date:  1968-07       Impact factor: 3.534

8.  Field stimulation as a means of effecting the graded release of autonomic transmitters in isolated heart muscle.

Authors:  J R Blinks
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

9.  Effect of propranolol on ventilatory function.

Authors:  R S McNeill; C G Ingram
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  3 in total

1.  The beta-adrenoceptor of the human lymphocyte and human lung parenchyma.

Authors:  M E Conolly; J K Greenacre
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

2.  Catecholamine transport in isolated lung parenchyma of pig.

Authors:  R G Goldie; J W Paterson
Journal:  Br J Pharmacol       Date:  1982-08       Impact factor: 8.739

3.  Effects of uptake inhibitors on responses of sheep coronary arteries to catecholamines and sympathetic nerve stimulation.

Authors:  F Brine; E J Cornish; R C Miller
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.